Home › NDC Lookup › RxCUI directory › RxCUI 2719335

Tolvaptan 15 MG Oral Tablet — RxCUI 2719335

RxNorm drug concept · Semantic clinical drug
RxCUI 2719335 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2719335
Official nameTolvaptan 15 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped14
Package NDCs mapped14
Reported Medicaid activity (SDUD)5,502 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tolvaptan (low blood sodium): what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Tolvaptan carries a serious risk of liver injury — including cases where patients needed a liver transplant. Because of that, the FDA requires it to be distributed only through a s...
  • Why do I need to go to a special pharmacy to get this medication?
  • Yes, that's actually the drug working as intended. Tolvaptan is designed to make your kidneys release more water, which dramatically increases how much you urinate. Many patients o...
  • I'm going to the bathroom constantly — is that normal?
📖 Read our full Tolvaptan (low blood sodium) guide →

🕸️ Concept Web — How Tolvaptan 15 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tolvaptan 15 MG Oral Tablet RxCUI 2719335

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tolvaptan 358257
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Jynarque 2044350
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tolvaptan Oral Tablet 849826
    • Tolvaptan Oral Product 1162746
    • Tolvaptan Pill 1162747
    • Tolvaptan Oral Tablet [Jynarque] 2044352
    • Jynarque Oral Product 2044353
    • Jynarque Pill 2044354
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 6

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 19 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

14 products · 14 package NDCs
14 package NDCs map to RxCUI 2719335 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59148-0079-28 4 BLISTER PACK in 1 CARTON (59148-079-28) / 1 KIT in 1 BLIS... Jynarque Otsuka America Pharmaceutical, Inc. 2020-01-13
59148-0080-28 4 BLISTER PACK in 1 CARTON (59148-080-28) / 1 KIT in 1 BLIS... Jynarque Otsuka America Pharmaceutical, Inc. 2020-01-13
59148-0082-13 1 BOTTLE in 1 CARTON (59148-082-13) / 30 TABLET in 1 BOTTLE JYNARQUE Otsuka America Pharmaceutical, Inc. 2018-04-23
59148-0083-13 1 BOTTLE in 1 CARTON (59148-083-13) / 30 TABLET in 1 BOTTLE JYNARQUE Otsuka America Pharmaceutical, Inc. 2018-04-23
59148-0087-28 4 BLISTER PACK in 1 CARTON (59148-087-28) / 1 KIT in 1 BLIS... Jynarque Otsuka America Pharmaceutical, Inc. 2018-04-23
59148-0088-28 4 BLISTER PACK in 1 CARTON (59148-088-28) / 1 KIT in 1 BLIS... Jynarque Otsuka America Pharmaceutical, Inc. 2018-04-23
59148-0089-28 4 BLISTER PACK in 1 CARTON (59148-089-28) / 1 KIT in 1 BLIS... Jynarque Otsuka America Pharmaceutical, Inc. 2018-04-23
70748-0238-06 30 TABLET in 1 BOTTLE (70748-238-06) TOLVAPTAN Lupin Pharmaceuticals, Inc. 2025-05-12
70748-0239-06 30 TABLET in 1 BOTTLE (70748-239-06) TOLVAPTAN Lupin Pharmaceuticals, Inc. 2025-05-12
70748-0240-13 4 BLISTER PACK in 1 CARTON (70748-240-13) / 1 KIT in 1 BLIS... TOLVAPTAN Lupin Pharmaceuticals, Inc. 2025-05-12
70748-0241-13 4 BLISTER PACK in 1 CARTON (70748-241-13) / 1 KIT in 1 BLIS... TOLVAPTAN Lupin Pharmaceuticals, Inc. 2025-05-12
70748-0242-13 4 BLISTER PACK in 1 CARTON (70748-242-13) / 1 KIT in 1 BLIS... TOLVAPTAN Lupin Pharmaceuticals, Inc. 2025-05-12
70748-0243-13 4 BLISTER PACK in 1 CARTON (70748-243-13) / 1 KIT in 1 BLIS... TOLVAPTAN Lupin Pharmaceuticals, Inc. 2025-05-12
70748-0244-13 4 BLISTER PACK in 1 CARTON (70748-244-13) / 1 KIT in 1 BLIS... TOLVAPTAN Lupin Pharmaceuticals, Inc. 2025-05-12
Observed labelers: Lupin Pharmaceuticals, Inc. (7) · Otsuka America Pharmaceutical, Inc. (7) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.